pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 27·1 min read
save

Thermo Fisher sells microbiology biz; Ligand to buy XOMA

Thermo Fisher Scientific sells microbiology business: Astorg, a European private equity firm, will acquire the unit for $1.075 billion. Thermo Fisher’s microbiology business is part of its specialty diagnostics segment, and ...

Apr 27, 2026·read at Endpoints ↗

April 27, 2026 11:17 AM EDT News Briefing Ther­mo Fish­er sells mi­cro­bi­ol­o­gy biz; Lig­and to buy XO­MA ENDPOINTS Ther­mo Fish­er Sci­en­tif­ic sells mi­cro­bi­ol­o­gy busi­ness: As­torg, a Eu­ro­pean pri­vate eq­ui­ty firm, will ac­quire the unit for $1.075 bil­lion. Ther­mo Fish­er’s … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
74 words · retrieved Apr 27
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
CRO/CDMO2Diagnostics Company

related stories

  • Aug 28CAR T for autoimmune disease benefits from oncology’s lessons—and will deliver its ownBioSpace
  • Aug 26Inside the Gulf biotech deal model, ahead of RGMBS 2026 in RiyadhBioSpace
  • Aug 4KKR inks $5.7B deal to take medtech manufacturing giant Integer privateFierce Biotech
  • Jul 1Opinion: What Ebola and Marburg are teaching us about the next pandemicSTAT
  • Jun 30Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot programBioPharma Dive